Team

Keith Elliston, PhD, is a seasoned entrepreneur who also spent 12 years in big pharma with Merck and Bayer. He has been involved in founding over a dozen biotechnology companies, including Sequana Therapeutics, Structural Genomics, Spotfire, and Genstruct/Selventa, and was CSO of Gene Logic helping lead its IPO. His scientific expertise is focused on systems biology, neurodegeneration, and cancer.

Rudy Potenzone, PhD has spent over 30 years delivering novel and integrated solutions to life science, biological, and chemical industries. Recent positions VP Marketing at the i2b2 tranSMART Foundation; at PerkinElmer as the VP of Product Strategy (Informatics); at Microsoft as worldwide pharma industry technology strategist; at MDL as VP of R&D;  and president of Lion Biosciences US.  ...

Rick Blevins, PhD has over 25 years of pharmaceutical research experience, and is an informatics expert – spanning from chemical informatics through to systems biology. Rick has led the bioinformatics efforts for Merck and GSK, and built the cyber infrastructure for Caris Life Sciences, and is the architect of the Virtual-Rx Charisma cyber-infrastructure and informatics platform.